FindTrial
Sign In

STUDY TO COMPARE THE EFFECT OF GIVING GROWTH HORMONE IN POOR RESPONDERS DURING IVF

ASSISTED REPRODUCTIVE TECHNIQUE OUTCOMES AFTER GROWTH HORMONE SUPPLEMENTATION IN POOR RESPONDERS UNDERGOING IN-VITRO FERTILISATION- A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018047
Enrollment
40
Registered
2019-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N978- Female infertility of other origin

Interventions

Intervention1: Growth hormone, Recombinant FSH (Gonal-F), Recombinant LH (Luveris) given: Growth hormone 5 mg (Novitropin) subcutaneous plus recombinant FSH (Gonal-F) 300 IU and Leutinizing Hormone

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Previous failed IVF with Poor ovarian reserve - S. AMH less than or equal to 1.2 ng/ml or Antral follicle count less than or equal to 5

Exclusion criteria

Exclusion criteria: Severe male factor infertility Severe endometriosis ( grade iv)

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rateTimepoint: 4 weeks after embryo transfer—

Secondary

MeasureTime frame
1) Live birth rate 2) Response to controlled ovarian stimulation 3) Fertilization rate 4) Cleavage rate 5) Embryo number and grade 6) Number of embryos available for cryopreservation 7) Implantation rate Timepoint: 9 months after embryo tranfer—

Countries

India

Contacts

Public ContactCHITHIRA P V

All India Institute of Medical Sciences, New Delhi

malhotraneena@yahoo.com9891557707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026